[1] |
KELLEY K A, BYRNE R, LU K C. Gastrointestinal stromal tumors of the distal gastrointestinal tract[J]. Clin Colon Rectal Surg, 2018, 31(5): 295-300.
doi: 10.1055/s-0038-1642053
|
[2] |
NILSSON B, BÜMMING P, MEIS-KINDBLOM J M, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era: a population-based study in western Sweden[J]. Cancer, 2005, 103(4): 821-829.
doi: 10.1002/cncr.20862
|
[3] |
PARAB T M, DEROGATIS M J, BOAZ A M, et al. Gastrointestinal stromal tumors: a comprehensive review[J]. J Gastrointest Oncol, 2019, 10(1): 144-154.
doi: 10.21037/jgo
|
[4] |
VALSANGKAR N, SEHDEV A, MISRA S, et al. Current management of gastrointestinal stromal tumors: surgery, current biomarkers, mutations, and therapy[J]. Surgery, 2015, 158(5): 1149-1164.
doi: 10.1016/j.surg.2015.06.027
|
[5] |
JAKHETIYA A, GARG P K, PRAKASH G, et al. Targeted therapy of gastrointestinal stromal tumours[J]. World J Gastrointest Surg, 2016, 8(5): 345-352.
doi: 10.4240/wjgs.v8.i5.345
|
[6] |
SØREIDE K, SANDVIK O M, SØREIDE J A, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies[J]. Cancer Epidemiol, 2016, 40: 39-46.
doi: 10.1016/j.canep.2015.10.031
|
[7] |
DUFFAUD F, LE CESNE A. Recent advances in managing gastrointestinal stromal tumor[J]. F1000Res, 2017, 6: 1689.
doi: 10.12688/f1000research
|
[8] |
LIU X, QIU H, ZHANG P, et al. Ki-67 labeling index may be a promising indicator to identify “very high-risk” gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients[J]. Hum Pathol, 2018, 74: 17-24.
doi: 10.1016/j.humpath.2017.09.003
|
[9] |
WADA R, ARAI H, KURE S, et al. "Wild type" GIST: clinicopathological features and clinical practice[J]. Pathol Int, 2016, 66(8): 431-437.
doi: 10.1111/pin.2016.66.issue-8
|
[10] |
KAMEYAMA H, KANDA T, TAJIMA Y, et al. Management of rectal gastrointestinal stromal tumor[J]. Transl Gastroenterol Hepatol, 2018, 3: 8.
doi: 10.21037/tgh
|
[11] |
LIU H L, YAN Z S, LIAO G Q, et al. Treatment strategy of rectal gastrointestinal stromal tumor (GIST)[J]. J Surg Oncol, 2014, 109(7): 708-713.
doi: 10.1002/jso.23562
|
[12] |
VON MEHREM M, RANDALL R L, BENJAMIN R S, et al. Soft tissue sarcoma, version 2. 2016, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2016, 14(6): 758-786.
doi: 10.6004/jnccn.2016.0078
|
[13] |
ESMO/EUROPEAN SARCOMA NETWORK WORKING GROUP. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2014, 25(Suppl 3): iii21-iii26.
|
[14] |
CASALI P G, ABECASSIS N, ARO H T, et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(suppl 4): iv68-iv78.
|
[15] |
中国医师协会外科医师分会胃肠道间质瘤诊疗专业委员会, 中华医学会外科学分会胃肠外科学组. 胃肠间质瘤规范化外科治疗中国专家共识(2018版)[J]. 中国实用外科杂志, 2018, 38(9): 965-973.
|
|
Professional Committee for Diagnosis and Treatment of Gastrointestinal Stromal Tumors, Branch of Surgeon, Chinese Medical Doctor Association; Gastrointestinal Surgery Group, Branch of Surgery, Chinese Medical Association. Consensus of Chinese experts on standardized surgical treatment of gastrointestinal stromal tumors (2018 Edition)[J]. Chin J Pract Surg, 2018, 38(9): 965-973.
|
[16] |
VON M M, RANDALL R L, BENJAMIN R S, et al. Soft tissue sarcoma, version 2.2018, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2018, 16(5): 536-563.
doi: 10.6004/jnccn.2018.0025
|
[17] |
CAI J Q, CHEN K, MOU Y P, et al. Laparoscopic versus open wedge resection for gastrointestinal stromal tumors of the stomach: a single-center 8-year retrospective cohort study of 156 patients with long-term follow-up[J]. BMC Surg, 2015, 15: 58.
doi: 10.1186/s12893-015-0040-2
|
[18] |
LI J, YE Y J, WANG J, et al. Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor[J]. Chin J Cancer Res, 2017, 29(4): 281-293.
doi: 10.21147/j.issn.1000-9604.2017.04.01
|